BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 10637198)

  • 1. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial Investigators.
    Bertrand ME; Esplugas E; Piessens J; Rasch W
    Circulation; 2000 Jan; 101(2):131-6. PubMed ID: 10637198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial.
    Davidson CJ; Laskey WK; Hermiller JB; Harrison JK; Matthai W; Vlietstra RE; Brinker JA; Kereiakes DJ; Muhlestein JB; Lansky A; Popma JJ; Buchbinder M; Hirshfeld JW
    Circulation; 2000 May; 101(18):2172-7. PubMed ID: 10801758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized prospective trial of ioxaglate 320 (Hexabrix) vs. iodixanol 320 (Visipaque) in patients undergoing percutaneous coronary intervention.
    Sutton AG; Ashton VJ; Campbell PG; Price DJ; Hall JA; de Belder MA
    Catheter Cardiovasc Interv; 2002 Nov; 57(3):346-52. PubMed ID: 12410513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial comparing the impact of a nonionic (Iomeprol) versus an ionic (Ioxaglate) low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty.
    Schräder R; Esch I; Ensslen R; Fach WA; Merle H; Scherer D; Sievert H; Spies HF; Zeplin HE
    J Am Coll Cardiol; 1999 Feb; 33(2):395-402. PubMed ID: 9973019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac events after low osmolar ionic or isosmolar nonionic contrast media utilization in the current era of coronary angioplasty.
    Le Feuvre C; Batisse A; Collet JP; Batisse JP; Choussat R; Beygui F; Helft G; Montalescot G; Metzger JP
    Catheter Cardiovasc Interv; 2006 Jun; 67(6):852-8. PubMed ID: 16649230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
    Jo SH; Youn TJ; Koo BK; Park JS; Kang HJ; Cho YS; Chung WY; Joo GW; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB; Kim HS
    J Am Coll Cardiol; 2006 Sep; 48(5):924-30. PubMed ID: 16949481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of iodixanol (Visipaque) and ioxaglate (Hexabrix) in coronary angiography and ventriculography: a double-blind randomized study].
    Roriz R; de Gevigney G; Finet G; Nantois-Collet C; Borch KW; Amiel M; Beaune J
    J Radiol; 1999 Jul; 80(7):727-32. PubMed ID: 10431273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media.
    Liss P; Persson PB; Hansell P; Lagerqvist B
    Kidney Int; 2006 Nov; 70(10):1811-7. PubMed ID: 17003814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous coronary angioscopic comparison of thrombus formation during percutaneous coronary angioplasty with ionic and nonionic low osmolality contrast media in unstable angina.
    Qureshi NR; den Heijer P; Crijns HJ
    Am J Cardiol; 1997 Sep; 80(6):700-4. PubMed ID: 9315572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse reactions of low osmolar non-ionic and ionic contrast media when used together or separately during percutaneous coronary intervention.
    Juergens CP; Khaing AM; McIntyre GJ; Leung DY; Lo ST; Fernandes C; Hopkins AP
    Heart Lung Circ; 2005 Sep; 14(3):172-7. PubMed ID: 16352273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate and late adverse reactions in coronary angiography. A comparison between iodixanol and ioxaglate.
    Fransson SG; Stenport G; Andersson M
    Acta Radiol; 1996 Mar; 37(2):218-22. PubMed ID: 8600966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonionic low-osmolar contrast media have no impact on major adverse cardiac events in patients undergoing coronary stenting with appropriate antiplatelet therapy.
    Danzi GB; Capuano C; Sesana M; Predolini S; Baglini R
    Catheter Cardiovasc Interv; 2003 Dec; 60(4):477-82. PubMed ID: 14624424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of ionic versus nonionic contrast medium during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction (GUSTO IIb). Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes.
    Batchelor WB; Granger CB; Kleiman NS; Phillips HR; Ellis SG; Betriu A; Criger DA; Stebbins AL; Topol EJ; Califf RM;
    Am J Cardiol; 2000 Mar; 85(6):692-7. PubMed ID: 12000041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty.
    Grines CL; Schreiber TL; Savas V; Jones DE; Zidar FJ; Gangadharan V; Brodsky M; Levin R; Safian R; Puchrowicz-Ochocki S; Castellani MD; O'Neill WW
    J Am Coll Cardiol; 1996 May; 27(6):1381-6. PubMed ID: 8626947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ionic and nonionic contrast media on endothelium and on arterial thrombus formation.
    Barstad RM; Buchmann MS; Hamers MJ; Orning L; Orvim U; Stormorken H; Sakariassen KS
    Acta Radiol; 1996 Nov; 37(6):954-61. PubMed ID: 8995473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodixanol in cardioangiography. A double-blind parallel comparison between iodixanol 320 mg I/ml and ioxaglate 320 mg I/ml.
    Tveit K; Bolz KD; Bolstad B; Haugland T; Berg KJ; Skjaerpe T; Kloster YF
    Acta Radiol; 1994 Nov; 35(6):614-8. PubMed ID: 7946687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of ionic and nonionic iodinated low-osmolar contrast media on platelet function with the PFA-100 (platelet function analyzer).
    D'Anglemont De Tassigny A; IDéE JM; Corot AC
    Invest Radiol; 2001 May; 36(5):276-82. PubMed ID: 11323515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of an ionic versus a nonionic low osmolar contrast agent on the thrombotic complications of coronary angioplasty.
    Piessens JH; Stammen F; Vrolix MC; Glazier JJ; Benit E; De Geest H; Willems JL
    Cathet Cardiovasc Diagn; 1993 Feb; 28(2):99-105. PubMed ID: 8448808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ionic and nonionic low osmolar contrast media in relation to thrombotic complications of angioplasty in patients with unstable angina.
    Malekianpour M; Bonan R; Lespérance J; Gosselin G; Hudon G; Doucet S; Laurier J; Duval D
    Am Heart J; 1998 Jun; 135(6 Pt 1):1067-75. PubMed ID: 9630113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotoxic effects in high-risk patients undergoing angiography.
    Aspelin P; Aubry P; Fransson SG; Strasser R; Willenbrock R; Berg KJ;
    N Engl J Med; 2003 Feb; 348(6):491-9. PubMed ID: 12571256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.